9Matsumoto J,minami T,Takami M ,et al.A case respectable hepatic metastases of breast cancer following intrahepaticarterial chemotherapy[J].CanTo Kagaku Ryoho(in Japanese), 1996,23:1542-1545.
10Ostadal B, Ostadalova I, Dhalla NS. Development of cardiac sensitivity to oxygen deficiency: comparative and ontogenetic aspects [J]. physiol Rev, 1999,79(3) :635-659.
1El Weshi A, Tulbah A, A1 Sayed A, et al. Triple negative breast cancer. A clinicopathological study of 113 cases and comparison with 55 cases with triple positive breast cancer: A match control analysis I J]. J Clin Oncol,2007,25 (18S,Part I) :A21119.
2Hayes DF, Thor AD, Dressier LG, et al. HER2 and response to paclitaxel in node-positive breast cancer[ J ]. N Engl J Med,2007,357 (5) : 1496 - 1506.
3Badve S, Turbin D, Thoratl MA, et al. FOXA1 expression in breast canc- er-correlation with luminal subtype A and survival [ J ]. Clin Cancer Res,2007,13(15 Pt 1) :4415 -4421.
4Carey LA, Dees EC, Sawye L, et al. The Triple Negative Paradox : Primary Tumor Chemosensitivity of Breast Cancer Subtypes [ J ]. Clin Cancer Res, 2007,13:2329 -2334.
5Sofia B, Lissandra dL, Chantal B, et al. Use of trastuzumab for the treat- ment of early stage breast cancer [ J]. Expet Rev Anticancer Ther,2006, 6(8) :1153 - 1164.
6Berry DA, Cirrincione C, Henderson IC, et al. Estrogen-receptor status and outcomes of modem chemotherapy for patients with node-positive breast cancer[ J]. JAMA ,2006,295 ( 14 ) : 1658 - 1667.
7Frederique Penanh-Llorca, Fabrice Andre, Christine Sagan, et al. Ki67 Expression and Docetaxel Efficacy in Patients with Estrogen Receptor- Positive Breast Cancer[ J]. Journal of Clinical Oncology ,2009,27 ( 17 ) : 2809 - 2815.
